Frank Karbe's Net Worth

Frank Karbe's net worth is estimated to be at least $1,906,693.28 as of 05/17/2024. CoreStreet's estimation of Frank Karbe's net worth is based on their sale of stock and current holding of stock.

Frank Karbe is CEO at Better Therapeutics Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 137,005 units of BTTX stock on 07/27/2023. Their biggest sale was on 08/31/2020 when they sold 24,800 units of Myovant Sciences Ltd stock for $496,496.00. They typically trade 2 times per year.

Total value of insider buys:
  • $476,101.33
Total value of insider sells:
  • $1,430,591.95
Most recent insider trade:
  • July 27, 2023

Frank Karbe's Insider Trading History

Better Therapeutics IncTitleAmountPriceTypeTotal Value
July 27, 2023
CEO137,005$0.73Buy$100,013.65
April 10, 2023
Insider242,424$0.82Buy$198,787.68
Sept. 15, 2022
Insider50,000$2.09Buy$104,500.00
Myovant Sciences LtdTitleAmountPriceTypeTotal Value
April 6, 2021
Insider11,080$18.63Sell$206,420.40
Jan. 28, 2021
Insider300$24.00Sell$7,200.00
Jan. 15, 2021
Insider750$21.50Sell$16,125.00
Dec. 28, 2020
Insider11,800$30.00Sell$354,000.00
Nov. 17, 2020
Insider750$20.00Sell$15,000.00
Nov. 13, 2020
Insider750$20.00Sell$15,000.00
Aug. 31, 2020
Insider24,800$20.02Sell$496,496.00
Aug. 19, 2020
Insider700$20.00Sell$14,000.00
Dec. 30, 2019
Insider19,701$15.55Sell$306,350.55
June 11, 2019
Insider8,000$9.10Buy$72,800.00